| INTRODUC TI ON
Ischemic stroke is one of the most common neurological disorders and a major cause of disability and death with limited transitional success of mounting stroke researches, posing an economic and societal burden. 1, 2 Under normal condition, the brain is under continuous immune surveillance and regulation. The neurovascular unit (NVU) regulates the homeostasis of brain microenvironment for normal neuronal activity. It is composed of neurons, glial cells (oligodendrocytes, microglia, and astrocytes) and vascular cells (endothelial cells, pericytes, and smooth muscle cells as well as the basal lamina matrix within brain vasculature). 3, 4 Compared to the concept of NVU, the notion of blood-brain barrier (BBB), which traditionally includes endothelia cells (ECs), astrocytes, pericytes, and the basal lamina matrix, tight junction proteins within the vasculature is more straight forward and more intensively studied. [5] [6] [7] [8] [9] [10] [11] [12] BBB damage is a common pathological feature shared by stroke and a variety of neurological diseases. [13] [14] [15] [16] [17] [18] Notably, it is closely
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blood-brain barrier, peripheral immune response, stroke associated with poor neurological outcomes. [19] [20] [21] [22] [23] In response to cerebral ischemic stroke, the brain can release a variety of "danger" signals or "help me" signals, such as ATP, high-mobility group box 1 (HMGB1), hypoxia-inducible factor 1α (HIF-1α), S100B, brain-derived antigens and et al, all of which activate multiple subsets of peripheral immune cells 24, 25 .Once activated, these cells can migrate to the ischemic brain through detection of chemoattractant gradients. [26] [27] [28] Upon BBB disruption, the components in blood including immune cells can enter into brain sequentially and interaction of neuro-immune interaction can be initiated. [29] [30] [31] [32] During their penetration through the injured BBB, these immune cells become a double edge sword, which could either exacerbate the BBB disruption or protect the integrity of BBB. 36, 37 Pleiotropic intracellular mechanisms and diverse secretory factors, including cytokines, proteolytic enzymes, exosomes, micro vesicles, and miRNAs, have been implicated in their interaction both in early disruption and later repair phase of the BBB. [33] [34] [35] [36] [37] Importantly, distinct phenotypes and subsets of immune cells exhibit diverse impact on the poststroke BBB. This review will discuss the dynamic changes of BBB integrity after stroke followed by a discussion of the double-faced roles of peripheral immune activation on the BBB integrity after stroke. Finally, the newly emerged mechanisms by which the peripheral immune cells impact the BBB integrity have also been covered at the end, including exosomes and micro vesicles.
| DYNAMIC CHANG E S OF B LOOD -B R AIN BARRIER INTEG RIT Y (B B B) AF TER S TROK E
In response to ischemic stroke, the integrity of BBB compromises promptly and changes dynamically, which can be observed by magnetic resonance imaging (MRI) and other imaging techniques. [38] [39] [40] [41] [42] During the early phase, cytoskeletal alterations in brain ECs can be initiated by actin polymerization followed by translocation of tight junctions (TJs) within 30-60 minutes of reperfusion through activation of the Rho-associated protein kinase (ROCK)/myosin.
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The activation of ROCK pathway may further promote the crosslinking of F-actin into force-generating linear stress fibers through the phosphorylation/activation of myosin light chains (MLC) and increase cytoskeletal tension thus lead to the disassembly of TJs.
These changes can widen the paracellular space between ECs, eventually resulting in hyperpermeability. 43 In addition, opening of sodium and calcium channels, endothelial connexin-43 hemichannels, the alterations in endocytotic vesicles, endothelial endocytosis/transcytosis, and transcellular vesicular trafficking, which could be mediated by caveolin-1, endothelial growth factor, or exocytotic machinery, may also account for BBB hyperpermeability as early as 6 hours after cerebral stroke. [44] [45] [46] [47] Increased expression of aquaporin 4 (AQP4) in astrocytes of the ischemic brain is also associated with the initial cerebral edema after stroke.
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Additionally, pericytes may separate from basement membrane and detach from endothelial cells through paracellular pathway or transcellular routes, which contributes to increased microvascular permeability via disruption of pericyte-tight junction interactions. [51] [52] [53] The expression of TJ proteins may be decreased due to increased oxidative stress or matrix metalloproteinases 9 (MMP9)-mediated protein degradation after stroke, leading to a "second wave" of increased BBB permeability. 40 Disruption of BBB integrity is not only a common consequence of stroke, but also contributes to the progression of stroke. 54, 55 Infarct size can progress with time after cerebral ischemia reperfusion, with more resident immune cells activated and more peripheral immune cells recruited to the brain and thereby further aggravates the injury of BBB. 56 Cerebral ischemia upregulates the expression of adhesion molecules, such as intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1),
integrin and E-selectin in the brain, which in turn facilitate a massive "second wave" of immune cell entry into the brain parenchyma through the BBB, leading to exacerbated neuroinflammation. The inflammation in the lesioned brain also contributes to the "second wave" of BBB disruption. 
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During the late phase of stroke, the BBB dysfunction becomes less severe, in which BBB restoration possibly plays an important role.
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Multiple processes may be involved in the restoration of BBB permeability after stroke at the late phase of stroke. Neovascularization begins in the peri-infarct region, which involves the proliferation of endothelial cells and sprouting of the vessels that eventually increase vascular density. 24 Astrocytes act to maintain endothelial permeability and survival after stroke through improving tight junction constituents. 52, 63 Pericytes can stable actin filaments in endothelial cells and preventing their death, guiding the correct location of endothelial cells, and clearing up neuronal debris during injury. 52, 64 The illustration of structural changes of ECs, TJs, astrocytes, and pericytes of the BBB after ischemic stroke is shown in Figure 1 .
| THE DOUB LE-FACED ROLE S OF PERIPHER AL IMMUNE AC TIVATI ON ON THE B B B INTEG RIT Y AF TER S TROK E
The injured ischemic brain can release ATP, high-mobility group box 1 (HMGB1), HIF-1α, S100B, brain-derived antigens and et al as alarm signals to activate the peripheral immune system through purinergic receptors, TLRs, and the receptor for advanced glycation endproducts (RAGE). 61 Once activated, these cells can migrate to areas of injury through detection of chemoattractant gradients. 24, 26 During their penetration through the injured BBB, these immune cells become a double edge sword, which could either exacerbate the BBB disruption or protect the integrity of BBB.
| Activated PMNS and BBB disruption after ischemic stroke
Polymorphonuclear neutrophils (PMNs) are the most abundant cell population present at the site of injury with a peak influx between 1 and 3 days in the ischemic brain. and infiltrating neutrophils can produce MMP9 after focal cerebral ischemia, which can be used to predict stroke patient outcome.
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In ischemic stroke patients, MMP9 increases in the plasma within the first 2 to 6 hours and the MMP9 mRNA in leukocytes increased within 3 hours 78 Activated neutrophils may be an important source of pre-existing intracellular MMP9 pool, which can be secreted in response to middle cerebral artery occlusion (MCAO) and oxygenglucose deprivation (OGD) insults 69 In addition, activated MMPs may also be triggered by increased TNF-α, IL-6, and α2-antiplasmin in the blood 79, 80 The granulocyte-colony stimulating factor (G-CSF) F I G U R E 1 Blood-brain barrier (BBB) integrity changes dynamically after ischemic stroke, BBB is composed of four major components, endothelia cells (ECs), basement membrane, astrocytes, and pericytes. After ischemic stroke, the structural of these cells changed. A, ECs: ECs are basic components and mainly connected by TJs to control the permeability of BBB. TJs comprise of junction adhesion molecules (JAM), claudins, and occludins, all of which are linked to the cytoskeleton via zonula occludens (ZO) protein. After ischemic stroke, cytoskeletal alterations in brain ECs are initiated by actin polymerization and increased cytoskeletal tension. Increased endocytosis/ transcytosis along with opening of ion channels and endothelial connexin-43 hemichannels on ECs also contribute to brain edema. Increased expression of adhesion molecules attracts peripheral immune cells to enter the brain and release immune factors. B, Pericytes: pericytes detach from ECs, widening paracellular spaces. Neurotoxic products influx into neurons, causing neuronal injury. C, Astrocytes: the expression of AQP4 water channels elevates on astrocytes and leads to brain edema. All of the above changes contribute to the disruption of BBB after stroke [Colour figure can be viewed at wileyonlinelibrary.com]
can stimulate the proliferation of peripheral neutrophils and thus increase the level of MMP9, leading to exacerbated BBB disruption and increased ischemic infarction. 81 In addition to MMP9,the elastase secreted by neutrophils also degrades basal lamina and extracellular matrix. 82 In mice lacking elastase, ischemia-induced BBB disruption is reduced, as is infarct volume and cerebral edema. Inhibiting elastase can further decrease infarct volume and BBB disruption in MMP9-null mice, suggesting an MMP9 independent mechanism of elastase on the BBB disruption.
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Besides MMP9 and elastase, neutrophils are important source of ROS in cerebral ischemia and reperfusion injury. ROS itself can disrupt the BBB through direct damage to endothelial cells, pericytes, smooth muscle cells, and astrocytes. 84 In addition, activated PMNs stimulate inflammatory cytokine production, which attracts more leukocytes from the periphery and aggravates the adhesion molecule expression on ECs, thus further propagates the postischemic inflammation cascade that exacerbates BBB disruption 85 and increases the risk of secondary bleeding within the ischemic focus. 
| Pleiotropic effects of microglia/macrophages on the BBB integrity after stroke
The function of microglia/macrophages function is complex and largely depends on the existence of varied, plastic, and multilayered macrophage phenotypes. 93 The impact of microglia/ macrophages activation on the ischemic BBB largely depends on the phenotype or status of these cells which can be affected by micro-environmental cues. [94] [95] [96] According to distinct cues, the microglia/macrophages can differentiate into two subtypes-inflammatory and antiinflammatory phenotypes. 97 In their proinflammatory phenotypes, they can aggravate the BBB injury while in their phagocytosis or antiinflammatory phenotypes they may play distinct roles toward BBB repair and regeneration.
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However, recent studies suggest that the terminology of microglia/macrophage polarization may be limited. Transcriptomic and proteomic profiles, regional heterogeneity, sexual dimorphism, and age could all take into account while determining the functions of microglia/macrophages. 102 The destructive effects on BBB are mainly mediated by M1 phenotypes which are characterized by the production of proin- has been suggested as a cell surface receptor associated with their phagocytosis function after ischemic stroke. 133 Phagocytosis by microglia/macrophages can also exert favorable effects through engulfment of infiltrated PMN. 
| Dualistic roles of T lymphocytes on the BBB integrity after stroke
Similar to neutrophils and microglia/macrophages, peripheral T lymphocytes infiltrated to the ischemic brain also exert dualistic roles on the evolution of BBB damage based on their different subtypes. 164, 165 In addition, the activation of the complement system, which is part of the innate immune response, has been described in clinical and experimental stroke. 166 The complement system also has dual roles during the injury and recovery of ischemic stroke. 167 It contributes to the recruitment and activation of immune cells, especially microglia, which may worsen BBB damage. 168 It also plays a role in stroke recovery by promoting the resolution of inflammation and regeneration. 169, 170 Despite the above findings, the relationship between these immune cells and the poststroke BBB integrity remains largely unknown and investigation in this regard would be of interesting and worthwhile.
In conclusion, the peripheral immune response is a double edge sword for the poststroke BBB. Distinct subtypes or phenotypes of immune cells may have diverse effects on the BBB disruption or repair at distinct phases after stroke (Figure 2 ). Understanding the roles of immune cells and their underlying mechanisms in BBB damage may help the development of promising BBB protective strategies for ischemic stroke patients.
| OTHER RELE A S ED S I G NALING FROM PERIPHER AL IMMUNE CELL S THAT MED IATE B B B D IS RUP TI ON OR PROTEC TI ON AF TER S TROK E
Over the past decades, enormous efforts have been put in explor- Releasing proteins, proteinases, cytokines, and chemokines constitutes as another important mechanism to impact the BBB, in which some of the cytokines and chemokines propagate the inflammatory cascade and degrade the BBB structure as discussed above while others promote the BBB recovery (Table 1 ). In addition, the peripheral immune cells may also affect the BBB disruption after stroke through releasing exosomes, microvesicles, and miRNAs.
| Exosomes
Emerging evidence is showing that activation of peripheral immune cells may release exosomes and microvesicles, both of which have been implicated in the evolving of BBB damage after stroke. pathway to mediate angiogenesis and to maintain BBB integrity.
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Thus, it is highly possible that there are specific subtypes of peripheral immune cells may release exosomes carrying BBB protective properties. However, studies in this regard are still warranted.
| Microvesicles
Microvesicles (MVs) are small membranous vesicles released from various cells in response to diverse biochemical agents or mechanical stresses. 202 Leukocyte-derived microvesicles (LMVs) are one of microvesicles, which act as proinflammatory mediators implicated in some diseases. 203, 204 LMVs originate from mature leukocytes, including monocyte, lymphocyte, and granulocytes. 205 It is suggested that LMVs are involved in the vascular inflammation in cardiovascular diseases and cerebrovascular diseases including stroke. 
| MicroRNAs
MicroRNAs are small noncoding RNAs that broadly affect cellular and physiological function in all multicellular organisms. More than 5000 miRNAs likely exist in humans and each miRNA binds an average of 200 RNAs. 210 MicroRNAs are divided into three categories, for example, proinflammatory, antiinflammatory, and mixed immunomodulatory. All of these regulate neuroinflammation in various pathologies, including spinal cord injury, multiple sclerosis, and ischemic stroke. 211 After ischemic stroke, miRNAs can also mediate BBB disruption by regulating gene expression at transcriptional and posttranscriptional levels. 212, 213 MiR-130a aggravates BBB leakage and brain edema via various ways. 214 It executes its damaging effects on BBB by downregulating HoxA5 and thereby reducing occludin expressions. 213 Besides HoxA5, microRNA-130a might act as a suppressor of aquaporin 4 by targeting its transcripts. 215 MiR-130a
can also reduce the expression of caveolin-1 and increase the level of MMP-2/9, which contributes to the increased permeability of BBB and increased perihematomal edema after intracerebral hemorrhage. 214 MiRNA-15a (miR-15a) has recently been shown to contribute to the pathogenesis of ischemic vascular injury through direct inhibition of the antiapoptotic gene bcl-2. 216 Of particular interest, miR-15a itself was found to be transcriptionally regulated by peroxisome proliferator-activated receptor (PPARδ). Administration of PPARδ agonist significantly reduced ischemia-induced miR-15a expression, increased bcl-2 protein levels, and attenuated caspase-3 activity, leading to decreased BBB disruption and reduced cerebral infarction in mice after transient focal cerebral ischemia. 216 In addition, miR-15a can suppress the angiogenesis in the peri-infarct region by decreasing FGF2 and VEGF levels, 217 thus downregulation miR-15a can promote angiogenesis and maintain BBB integrity.
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Overexpression of let-7 and miR-98 in vitro and in vivo resulted in reduced leukocyte adhesion to and migration across endothelium, diminished expression of proinflammatory cytokines, and increased BBB tightness, attenuating barrier "leakiness" in neuroinflammation conditions. 212 Therefore, a variety miRNAs could be used as a therapeutic tool to prevent neuroinflammation and BBB dysfunction.
Recent findings in exosomes, microvesicles, and miRNAs have evidenced that their releases from peripheral immune cells play critical roles in the evolution of BBB pathology after stroke. Notably, exosomes, microvesicles, and miRNAs released from distinct immune cells under distinct contexts may exert divergent roles on the BBB integrity after stroke.
| SUMMARY AND CON CLUS I ON
Targeting the highly dynamic events that occur during stroke in the relatively inaccessible brain microenvironment is challenging. TA B L E 1 Immune cell produced factors that impact blood-brain barrier (BBB) integrity after stroke 36, 69, 89, 193, 194 Facilitate tissue remodeling, activate bound growth factors: VEGF-A, regulate pro-angiogenesis TJ, tight junction; ICAM-1, intercellular adhesion molecule; MMP, matrix metalloproteinase enzymes; PKC, protein kinase C; eNOS, endothelial nitric oxide synthase; ROS, reactive oxygen species; GTPase, guanosine triphosphatase; RhoA, Ras homolog gene family, member A; MIF, macrophage migration inhibitory factor; IFN-γ, interferon gamma; TNF-α, tumor necrosis factor alpha; NK cell, natural killer cell; CCR5, C-C chemokine receptor type 5; CCL2, chemokine (C-C motif) ligand 2; HMGB1, high-mobility group box-1 protein; TGF-β, transforming growth factor beta; EC, endothelial cell; LCN-2, lipocalin-2; VEGF, vascular endothelial growth factor; HIF-1α, hypoxia-inducible factor-1 
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